The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management
Open accessAbstract
BACKGROUND: Glucocorticoids (GCs) are frequently used to treat glomerular diseases but are associated with multiple adverse effects including hypothalamic-pituitary-adrenal axis inhibition that can lead to adrenal insufficiency (AI) on withdrawal. There is no agreed GC tapering strategy to minimise this risk. METHODS: This is a single centre retrospective study, between 2013 to 2016, of patients with glomerular disease on GC therapy for more than 3 months screened for GC induced AI with short synacthen stimulation tests (SSTs) done prior to complete GC withdrawal. We investigated the prevalence of AI, predictors, choice of screening tool and recovery. RESULTS: Biochemical evidence of GC induced AI was found in 57 (46.3%) patients. Total duration of GC did not differ between those with and without AI (p = 0.711). Patients with GC induced AI had a significantly lower pre-synacthen baseline cortisol as compared to patients without AI. A cut off pre-synacthen baseline cortisol of ≥223.5 nmol/l had a specificity of 100% for identifying individuals without biochemical AI. Patients with GC induced AI took a mean of 8.7 ± 4.6 months (mean ± SD) to recover. Patients with persistent AI had a significantly lower index post-synacthen cortisol measurement. CONCLUSIONS: We demonstrate that biochemically proven GC induced AI is common in patients with glomerular diseases, is not predicted by daily dose or duration and takes a considerable time to recover. The study supports the use of morning basal cortisol testing as an appropriate means to avoid the need for SSTs in all patients and should be performed in all patients prior to consideration of GC withdrawal after 3 months duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is certain that the administration of oral GCs, long-term and in high doses, may cause GC-induced AI [7,8,9,10].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Glucocorticoid-induced adrenal insufficiency
Krasner, A. S. (1999) · JAMA · doi:10.1001/jama.282.7.671 · Cited by 197
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179
Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152
Self-citationPoon, P. C., & Smith, J. F. (1996) · PubMed · Cited by 143
Agha, A., Tomlinson, J. W., Clark, P. M., Holder, G., & Stewart, P. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1131 · Cited by 141
Hurel, S. J., Thompson, C. J., Watson, M. J., Harris, M. M., Baylis, P. H., & Kendall‐Taylor, P. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.555381.x · Cited by 138
Long‐term follow‐up of bone mineral density in Addison's disease
Jódar, E., Valdepeñas, M. P. R., Martínez, G., Jara, A., & Hawkins, F. G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01761.x · Cited by 85
Is a 0900-h serum cortisol useful prior to a short Synacthen test in outpatient assessment?
le Roux, C., Meeran, K., & Alaghband-Zadeh, J. (2002) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563021901919 · Cited by 77
Cited by
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Cortisol excess in chronic kidney disease – A review of changes and impact on mortality
Sagmeister, M. S., Harper, L., & Hardy, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075809 · Cited by 93
Self-citationRituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
Tieu, J., Smith, R., Basu, N., Brogan, P. A., D’Cruz, D. P., Dhaun, N., Floßmann, O., Harper, L., Jones, R. B., Lanyon, P., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez640 · Cited by 72
Self-citationPelewicz, K., & Miśkiewicz, P. (2021) · Diagnostics · doi:10.3390/diagnostics11040728 · Cited by 44
Perioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Metadata
- Authors
- Karangizi, A. H. K., Al-Shaghana, M., Logan, S., Criseno, S., Webster, R., Boelaert, K., Hewins, P., & Harper, L.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Harper, Lorraine
- Venue
- BMC Nephrology
- Published
- 2019-05-06
- Volume
- 20
- Issue
- 1
- Pages
- 154-154
- ISSN
- 1471-2369 (ISSN-L)
- PMC
- PMC6503364
- OpenAlex
- W2947597872
- Cited by
- 23
- References
- 20
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 2
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Nephrology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Funders
- National Institute for Health Research (Academic Clinical Fellowship)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- glucocorticoid-induced adrenal insufficiency, glomerular disease, glucocorticoid withdrawal, corticosteroid tapering, hypothalamic-pituitary-adrenal axis, corticosteroid adverse effects
- MeSH terms
- Adrenal Insufficiency, Cosyntropin, Female, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Kidney Diseases, Kidney Glomerulus, Male, Methylprednisolone, Middle Aged, Pituitary-Adrenal System, Prednisolone, Retrospective Studies, ROC Curve, Time Factors, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management. https://app.cochat.ai/papers/10.1186/s12882-019-1354-6
- The paper
- Karangizi, A. H. K., Al-Shaghana, M., Logan, S., Criseno, S., Webster, R., Boelaert, K., Hewins, P., & Harper, L. (2019). Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management. BMC Nephrology. https://doi.org/10.1186/s12882-019-1354-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.